These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2474899)

  • 1. Follow-up of anti-IgA antibodies in primary immunodeficient patients treated with gamma-globulin.
    Ferreira A; García Rodriguez MC; Fontán G
    Vox Sang; 1989; 56(4):218-22. PubMed ID: 2474899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-IgA antibodies in selective IgA deficiency and in primary immunodeficient patients treated with gamma-globulin.
    Ferreira A; Garcia Rodriguez MC; Lopez-Trascasa M; Pascual Salcedo D; Fontan G
    Clin Immunol Immunopathol; 1988 May; 47(2):199-207. PubMed ID: 2450712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of anti-IgA antibodies in causing adverse reactions to gamma globulin infusion in immunodeficient patients: a comprehensive review of the literature.
    Rachid R; Bonilla FA
    J Allergy Clin Immunol; 2012 Mar; 129(3):628-34. PubMed ID: 21835445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-immunoglobulin antibodies in immunodeficiencies: their influence on intolerance reactions to gamma-globulin administration.
    Ropars C; Caldera LH; Griscelli C; Homberg JC; Salmon C
    Vox Sang; 1974; 27(4):294-301. PubMed ID: 4137541
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoglobulins on the surface of lymphocytes in fifty patients with primary immunodeficiency diseases.
    Preud'Homme JL; Griscelli C; Seligmann M
    Clin Immunol Immunopathol; 1973 Jan; 1(2):241-56. PubMed ID: 4128503
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous immune serum globulin in immunodeficiency.
    Cunningham-Rundles C
    Vox Sang; 1985; 49 Suppl 1():8-14. PubMed ID: 2416128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behavior of serum immunoglobulins during and after intravenous administration of gamma globulin in subjects with antibody deficiency syndromes].
    Gravina E; Gravina-Sanvitale G
    Minerva Pediatr; 1975 Jun; 27(20):1166-70. PubMed ID: 49009
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-IgA antibody associated reactions to intravenous gammaglobulin in a patient who tolerated intramuscular gammaglobulin.
    Frankel SJ; Polmar SH; Grumet FC; Wedner HJ
    Ann Allergy; 1986 May; 56(5):436-9. PubMed ID: 2422990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary immunodeficiency.
    Rosen FS
    Pediatr Clin North Am; 1974 Aug; 21(3):533-49. PubMed ID: 4137895
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-IgA screening and use of IVIG.
    Hunt AF; Reed MI
    Lancet; 1990 Nov; 336(8724):1197. PubMed ID: 1700247
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of primary immunodeficiencies with intravenous gamma globulin].
    García Rodríguez C; López Trascasa M; Ferreira Cerdán A; Fontán Casariego G
    An Esp Pediatr; 1987 Dec; 27(6):411-5. PubMed ID: 2451892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-immunoglobulin antibodies in immunologically deficient patients. Value of their determination in intolerance reactions to therapeutic gamma globulin injections].
    Caldera LH; Ropars C; Griscelli C; Homberg JC; Salmon C
    Rev Fr Transfus; 1973 Dec; 16(4):393-402. PubMed ID: 4135408
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is there any clinical significance to anti-IgA antibodies which appear in patients with immunodeficiencies treated with intravenous gamma globulin?].
    Ferreira A; Cruz García Rodríguez M; Martín J; Fontán G
    Sangre (Barc); 1995 Jun; 40(3):171-3. PubMed ID: 7570266
    [No Abstract]   [Full Text] [Related]  

  • 14. Gammaglobulin treatment and anti-IgA antibodies in IgA-deficient patients.
    Koistinen J; Heikkilä M; Leikola J
    Br Med J; 1978 Sep; 2(6142):923-4. PubMed ID: 81700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-IgA antibodies in IgA-deficient children.
    Sennhauser FH; Hosking CS; Jones CL; MacDonald RA; Mermelstein N; Roberton DM
    J Clin Immunol; 1988 Sep; 8(5):356-61. PubMed ID: 3263381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of anti-IgA antibodies with adverse reactions to γ-globulin infusion.
    Rachid R; Castells M; Cunningham-Rundles C; Bonilla FA
    J Allergy Clin Immunol; 2011 Jul; 128(1):228-230.e1. PubMed ID: 21397310
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined immunodeficiency disease with response to transfer factor.
    Strauss RG; Hake DA
    J Pediatr; 1974 Nov; 85(5):680-2. PubMed ID: 4421305
    [No Abstract]   [Full Text] [Related]  

  • 18. Long term use of intravenous immune globulin in patients with primary immunodeficiency diseases: inadequacy of current dosage practices and approaches to the problem.
    Buckley RH
    J Clin Immunol; 1982 Apr; 2(2 Suppl):15S-21S. PubMed ID: 6806314
    [No Abstract]   [Full Text] [Related]  

  • 19. The significance of the presence of anti-IgA antibodies in individuals with an IgA deficiency.
    Nadorp JH; Voss M; Buys WC; van Munster PJ; van Tongeren JH; Aalberse RC; van Loghem E
    Eur J Clin Invest; 1973 Jul; 3(4):317-23. PubMed ID: 4543375
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies.
    Björkander J; Hammarström L; Smith CI; Buckley RH; Cunningham-Rundles C; Hanson LA
    J Clin Immunol; 1987 Jan; 7(1):8-15. PubMed ID: 3494039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.